“…Nowadays, the survival expectancy of patients has increased thanks to the development of stereotactic radiosurgery and systemic therapies. In addition, treatment approaches and prognostic classifications of BM have evolved according to primary tumor characteristics 9,10 . Thus, tumors' cellular and genetic patterns are considered in treatment selection.…”